Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Burlington, WI
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Burlington, WI
Vocal Acoustic Biomarkers in Depression
Development of a Convenient, Automated, Objective Measure of Depression
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Vocal Acoustic Biomarkers in Depression
Development of a Convenient, Automated, Objective Measure of Depression
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Vocal Acoustic Biomarkers in Depression
Development of a Convenient, Automated, Objective Measure of Depression
Status: Archived
South Cove Community Health Center
mi
from
Boston, MA
Vocal Acoustic Biomarkers in Depression
Development of a Convenient, Automated, Objective Measure of Depression
Status: Archived
Updated: 1/1/1970
South Cove Community Health Center
mi
from
Boston, MA
Depressed Adolescents Treated With Exercise (The DATE Study)
Exercise Treatment for Depressed Youth
Status: Archived
University of Texas - Southwest
mi
from
Dallas, TX
Depressed Adolescents Treated With Exercise (The DATE Study)
Exercise Treatment for Depressed Youth
Status: Archived
Updated: 1/1/1970
University of Texas - Southwest
mi
from
Dallas, TX
Depressed Adolescents Treated With Exercise (The DATE Study)
Exercise Treatment for Depressed Youth
Status: Archived
The Cooper Institute
mi
from
Dallas, TX
Depressed Adolescents Treated With Exercise (The DATE Study)
Exercise Treatment for Depressed Youth
Status: Archived
Updated: 1/1/1970
The Cooper Institute
mi
from
Dallas, TX
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Lansing, MI
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lansing, MI
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Omaha, NE
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Omaha, NE
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Las Vegas, NV
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Las Vegas, NV
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
American Fork, UT
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
American Fork, UT
Neuroimaging for Depression
Objective Detection, Evaluation and Countermeasures for In-flight Depression
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Neuroimaging for Depression
Objective Detection, Evaluation and Countermeasures for In-flight Depression
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Quetiapine XR Monotherapy or Adjunctive Therapy to Antidepressants in the Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Quetiapine XR Monotherapy or Adjunctive Therapy to Antidepressants in the Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Uc Irvine Medical Center
mi
from
Orange, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Uc Irvine Medical Center
mi
from
Orange, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
California Neuropsychopharmacology Clinical Research Institute (CNRI)
mi
from
San Diego, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
California Neuropsychopharmacology Clinical Research Institute (CNRI)
mi
from
San Diego, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
University of Colorado, Boulder
mi
from
Boulder, CO
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
mi
from
Boulder, CO
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Tampa VAMC
mi
from
Tampa, FL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Tampa VAMC
mi
from
Tampa, FL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
American Medical Research, Inc.
mi
from
Oak Brook, IL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
American Medical Research, Inc.
mi
from
Oak Brook, IL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Sheppard Pratt Health System
mi
from
Baltimore, MD
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Sheppard Pratt Health System
mi
from
Baltimore, MD
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Capitol Clinical Research
mi
from
Rockville, MD
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Capitol Clinical Research
mi
from
Rockville, MD
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Social Psychiatric Research Institute
mi
from
Brooklyn, NY
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Social Psychiatric Research Institute
mi
from
Brooklyn, NY
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Lake Cardiology
mi
from
Mount Dora, FL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Lake Cardiology
mi
from
Mount Dora, FL
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Metro Health Medical Center
mi
from
Cleveland, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Metro Health Medical Center
mi
from
Cleveland, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Mood Disorders Program at University Hospitals of Cleveland
mi
from
Cleveland, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Mood Disorders Program at University Hospitals of Cleveland
mi
from
Cleveland, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Midwest Clinical Research Center
mi
from
Dayton, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Midwest Clinical Research Center
mi
from
Dayton, OH
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
FutureSearch Clinical Trials
mi
from
Austin, TX
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
FutureSearch Clinical Trials
mi
from
Austin, TX
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Synergy Clinical Research
mi
from
Escondido, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Synergy Clinical Research
mi
from
Escondido, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Excell Research, Inc.
mi
from
Oceanside, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Excell Research, Inc.
mi
from
Oceanside, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Uc Irvine Medical Center
mi
from
Orange, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
Uc Irvine Medical Center
mi
from
Orange, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
California Neuropsychopharmacology Clinical Research Institute (CNRI), LLC
mi
from
Pico Rivera, CA
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Archived
Updated: 1/1/1970
California Neuropsychopharmacology Clinical Research Institute (CNRI), LLC
mi
from
Pico Rivera, CA